Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1487-1491

  Lorberboym, Mordechai ^a,b   Murthy, Sumathy ^a   Mechanick, Jeffrey I ^a   Bergman, Donald ^a   Morris, John C ^a   Kim, Chun K ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

iodine 131; thallium 201; thyroglobulin; thyroid carcinoma; thyroidectomy

Indexed keywords

IODINE 131; THALLIUM 201; THYROGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS;

EID: 0029783802     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-28.
2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
3. Hurley JR, Becker DV. The use of radioiodine in the management of thyroid cancer. In: Nuclear medicine annual. Freeman LM, Weissman HS, eds. New York: Raven, 1983:329-384.
4. Ramanna L, Waxman A, Braunstein G. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med 1991;32:441-446.
5. Robbins J. Thyroid suppression therapy for prevention of thyroid tumors after radiation exposure. In: Radiation-associated thyroid carcinoma. Degroot LJ, Frohman LA, Kaplan EL, Refetoff S, eds. New York: Grune & Stratton Inc.; 1977:419-431.
6. 201Tl scintigraphy and scrum thyroglobulin measurement. J Nucl Med 1991;32:2098-2100.
7. 201Tl total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 1986;27;1854-1857.
8. 131I. Radiology 1980;136:461-464.
9. Dadparvar S, Krishna L, Brady LW, Slizofski WJ, Brown SJ, Chevres A, Micaily B. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer 1993;71:3767-3773.
10. Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G. Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1988;29:1515-1520.
11. 131I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab 1973;36:1143-1152.
12. Krishna L, Dadparvar S, Brady LW, et al. Paradoxical changes in iodine-131 scintigraphic findings in advanced follicular thyroid cancer. J Nucl Med 1993;34: 1574-1576.